Idris, I. (2024). Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied. Wiley. https://doi.org/10.1002/doi2.109
Cita Chicago Style (17a ed.)Idris, Iskandar. Potential New Therapies to Preserve Lean Muscle Mass Loss When Used in Combination with Glucagon‐like Peptide 1 (GLP‐1) Receptor Agonist Being Studied. Wiley, 2024. https://doi.org/10.1002/doi2.109.
Cita MLA (9a ed.)Idris, Iskandar. Potential New Therapies to Preserve Lean Muscle Mass Loss When Used in Combination with Glucagon‐like Peptide 1 (GLP‐1) Receptor Agonist Being Studied. Wiley, 2024. https://doi.org/10.1002/doi2.109.
Precaución: Estas citas no son 100% exactas.